Literature DB >> 30856148

Clinical application of diffusion-weighted magnetic resonance imaging in radiotherapy for nasopharyngeal carcinoma.

Jifei Xu1, Kun Zhang2, Hongyan Wang1, Zhenzhen Cui3, Yi Wu3, Wanqin Wang4, Fan Wang1.   

Abstract

OBJECTIVE: To explore the clinical application of diffusion-weighted magnetic resonance imaging (DWI) in nasopharyngeal carcinoma (NPC) diagnosis, detection of lymph node metastasis, radiotherapy and prognosis.
METHODS: Twenty patients with diagnosed NPC in an early stage of radiotherapy were enrolled in our department between May 2010 and May 2013. T1 and T2 weighted magnetic resonance imaging and DWI of the nasopharynx and neck were performed 1 week before radiotherapy, during radiotherapy at a dose of 60 Gy, and 1 month after radiotherapy. Pertinent measurements and related data were recorded.
RESULTS: In comparison with that before radiotherapy, the ADC value of the nasopharyngeal primary lesion increased significantly during radiotherapy at a dose of 60 Gy and at 1 month after radiotherapy (F = 187.160, P = 0.000). When the dose of radiotherapy reached 60 Gy, the DWI signals from both the neck and the retropharyngeal lymph nodes were significantly lower than those before radiotherapy.
CONCLUSION: DWI can be used for sensitive and accurate diagnosis of lymph node metastasis in the neck and retropharyngeal space, monitoring of the radiotherapy effect in early stages of NPC and development of new medical treatment strategies.

Entities:  

Keywords:  Magnetic resonance imaging; nasopharyngeal cancer; radiotherapy

Mesh:

Year:  2019        PMID: 30856148     DOI: 10.3233/XST-180441

Source DB:  PubMed          Journal:  J Xray Sci Technol        ISSN: 0895-3996            Impact factor:   1.535


  1 in total

1.  Baseline Amide Proton Transfer Imaging at 3T Fails to Predict Early Response to Induction Chemotherapy in Nasopharyngeal Carcinoma.

Authors:  Zhou Liu; Liyan Zou; Qian Yang; Long Qian; Tianran Li; Honghong Luo; Canwen Che; Yuanyuan Lei; Peng Chen; Chunyan Qiu; Xin Liu; Yin Wu; Dehong Luo
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.